Safe use of Olygose GOS supported by new peer-reviewed publications

4544d2c6-35bd-4de1-9d0a-d8bec1551271articleimage.jpg

18 Sep 2017 --- French natural ingredients manufacturer Olygose has announced that new peer-reviewed publications support the safe use of plant-based galacto-oligosaccharides (GOS) from Olygose from infancy to older age.

“We have reached an important milestone with the publication of this safety data set,” says François Delbaere, CEO of Olygose. “The excellent safety profile observed will definitely support the expansion of our presence on the market and greatly facilitate the regulatory challenges that any company that is involved in specialized nutrition markets, such as infant nutrition, has to face.”

Olygose Friday announced the release of two new publications confirming the safety of plant-based galacto-oligosaccharides evaluated during a 90-day sub-chronic toxicity test in rats (OECD guideline 408) and a repeated dose study in piglets. The two manuscripts have been published in Toxicology Research and Application during summer and are available here.

Separate trials produce safety-affirming results
The 90-day sub-chronic toxicity trial, performed with CiToxLAB (France), aimed at providing information on health hazards likely to arise from exposure to plant-based GOS via oral administration and indicated that the no observed adverse effect level (NOAEL) for Olygose plant-based GOS is greater than 2000 mg per kg per day.

The neonatal piglet trial, performed with US toxicology testing and research laboratory Experimur, demonstrated that plant-based GOS incorporated at a level of 8 g/L in a formula (the maximum dose of prebiotic substance added to infant formulas) was well tolerated and did not cause harmful effects. The neonatal piglet is the best translational model available to date to evaluate the safety of new substances aimed at being incorporated in infant formulas.

Olygose says its plant-based GOS are produced in France “thanks to a proprietary technology resulting in very pure ingredients suitable for a number of applications in the field of foods, beverages and supplements.” They are currently marketed in Europe and the US under different brand names, namely AlphaGOS for prebiotic and symbiotic formulations, CravingZ’Gone for satiety and weight management and P-GOS for infant nutrition applications.

Olygose points out in its press release that its proprietary syrups and powders offer clinically-supported benefits in fields such as microbiome implantation and efficiency, satiety and metabolic syndrome. It says their taste and processing characteristics provide for an easy incorporation in infant formulas and baby foods, as well as in dietary supplements.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

GOS holds dietary fiber potential: FrieslandCampina eyes new applications

13 Aug 2018 --- FrieslandCampina is targeting the dietary fiber opportunity for its Galacto-Oligosaccharides (GOS). The move comes in response to the recent FDA green light on specific dietary fibers which presents new market opportunities and application areas. “There is a lot of interest in clean, green and label-friendly ingredients and fiber is one that they are looking for, but in good tasting applications. This really means a lot more flexibility for formulators to offer something that has both prebiotic and fiber benefits,” Sarah Staley of FrieslandCampina tells NutritionInsight on the topic of GOS as a trending prebiotic fiber.

Health & Nutrition News

NZMP: BifidoB infant nutrition ingredient found to help protect against infection

11 Jul 2018 --- A study has found that NZMP SureStart BifidoB 019 supplemented formula can help reduce physician-confirmed infections as well as the need for prescribed antibiotic or antiviral medication in infants aged 6-15 months consuming the formula relative to an unsupplemented control group.

Health & Nutrition News

Infant nutrition (part 2): Innovations in feeding the first 1,000 days

20 Jun 2018 --- Although breast milk is the most nutritious and advisable way to feed an infant for the first six months of life, as advised by the World Health Organization, there are situations that necessitate good quality breast milk substitutes. Part one of this two-part series on infant nutrition focused on the R&D challenges facing formula manufacturers. This second section focuses on the innovations in the ever-evolving market of Breast Milk Substitutes (BMS), as shared by a range of suppliers, as well as a look at the upcoming trends.

Health & Nutrition News

“Dietary fibers” classification: US FDA green lights eight ingredients

15 Jun 2018 --- The US Food and Drug Administration (FDA) has issued guidance which identifies eight specific fibers that can be classified as “dietary fibers” on the upcoming Nutrition Facts Label, marking the end of two years of uncertainty for manufacturers. In 2016, the FDA initially announced a new regulatory definition for dietary fiber and stated that to be considered a source of fiber, isolated or synthetic non-digestible carbohydrates must have a demonstrated physiological health benefit.

Health & Nutrition News

Gut health (part 2): Probiotic growth to continue

30 May 2018 --- As knowledge of the gut microbiome increases, probiotics have experienced a huge surge in popularity. Not only can they boost the overall health of the microbiome but specific strains can provide answers to some medical conditions. In this report, NutritionInsight notes the importance of scientific research for probiotic strains, growing market applications and novel delivery forms, as informed by Ganeden, Kerry, Fonterra and Anlit. In part one of the gut health series, functional fiber was the focus.

More Articles
URL : http://www.nutritioninsight.com:80/news/safe-use-of-olygose-gos-supported-by-new-peer-reviewed-publications.html